312 Understanding the intricate balance of ROS in tumor biology is key to developing targeted therapies that can modulate ROS levels to inhibit tumor growth effectively
No: they do not directly activate the GLP-1 receptor in the same way as semaglutide or liraglutide, and do not have the same clinical evidence
Additional questions include how to mitigate lean muscle mass loss, which is important for joint stability, and whether adding glucose-dependent insulinotropic polypeptide or glucagon receptor activation could offer advantages over GLP-1 agonists on their own
Quick Answer: Individuals with personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, known hypersensitivity to these medications, pregnant or breastfeeding women, and those with certain medical conditions should not take weight loss injections without careful medical evaluation
And is it healthy
Other Oral GLP-1 Options: Liraglutide (Saxenda): Injectable only (not oral) Daily injections required Older GLP-1 medication Less effective than semaglutide or tirzepatide Not available in oral form Dulaglutide (Trulicity): Injectable only (not oral) Once-weekly injection Primarily for diabetes Not available in oral form Exenatide (Byetta, Bydureon): Injectable only (not oral) Twice daily or once weekly depending on formulation Older GLP-1 medication Not available in oral form Bottom Line on Current Options: If you want an oral GLP-1 medication right now, Rybelsus is your only option, but its significantly less effective for weight loss than injections